Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 493

1.

GLP-1 Receptor Agonist Exendin-4 Attenuates NR4A Orphan Nuclear Receptor NOR1 Expression in Vascular Smooth Muscle Cells.

Takahashi H, Nomiyama T, Terawaki Y, Kawanami T, Hamaguchi Y, Tanaka T, Tanabe M, Bruemmer D, Yanase T.

J Atheroscler Thromb. 2018 Jun 30. doi: 10.5551/jat.43414. [Epub ahead of print]

2.

HMGA1a Induces Alternative Splicing of the Estrogen Receptor-αlpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5' Splice Site.

Ohe K, Miyajima S, Tanaka T, Hamaguchi Y, Harada Y, Horita Y, Beppu Y, Ito F, Yamasaki T, Terai H, Mori M, Murata Y, Tanabe M, Abe I, Ashida K, Kobayashi K, Enjoji M, Nomiyama T, Yanase T, Harada N, Utsumi T, Mayeda A.

Front Mol Biosci. 2018 Jun 8;5:52. doi: 10.3389/fmolb.2018.00052. eCollection 2018.

3.

Expansion of transplanted islets in mice by co-transplantation with adipose tissue-derived mesenchymal stem cells.

Tanaka T, Kojima D, Mera T, Matsumoto M, Yasunami Y, Yanase T.

Heliyon. 2018 May 17;4(5):e00632. doi: 10.1016/j.heliyon.2018.e00632. eCollection 2018 May.

4.

Efficacy and safety of sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION).

Nomiyama T, Shimono D, Horikawa T, Fujimura Y, Ohsako T, Terawaki Y, Fukuda T, Motonaga R, Tanabe M, Yanase T; Collaborators of Fukuoka Study of Ipragliflozin (FUSION) trial.

Endocr J. 2018 May 26. doi: 10.1507/endocrj.EJ18-0022. [Epub ahead of print]

5.

Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.

Abe I, Sugimoto K, Miyajima T, Ide T, Minezaki M, Takeshita K, Takahara S, Nakagawa M, Fujimura Y, Kudo T, Miyajima S, Taira H, Ohe K, Ishii T, Yanase T, Kobayashi K.

Intern Med. 2018 Apr 27. doi: 10.2169/internalmedicine.0550-17. [Epub ahead of print]

6.

HMGA1a induces alternative splicing of estrogen receptor alpha in MCF-7 human breast cancer cells.

Ohe K, Miyajima S, Abe I, Tanaka T, Hamaguchi Y, Harada Y, Horita Y, Beppu Y, Ito F, Yamasaki T, Terai H, Mori M, Murata Y, Tanabe M, Ashida K, Kobayashi K, Enjoji M, Yanase T, Harada N, Utsumi T, Mayeda A.

J Steroid Biochem Mol Biol. 2018 Apr 17. pii: S0960-0760(18)30212-7. doi: 10.1016/j.jsbmb.2018.04.007. [Epub ahead of print]

PMID:
29678492
7.

Epizootic Hemorrhagic Disease Virus Serotype 6 Infection in Cattle, Japan, 2015.

Kamomae Y, Kamomae M, Ohta Y, Nabe M, Kagawa Y, Ogura Y, Kato T, Tanaka S, Yanase T, Shirafuji H.

Emerg Infect Dis. 2018 May;24(5):902-905. doi: 10.3201/eid2405.171859.

8.

New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.

Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y, Ichijo T.

Endocr J. 2018 Apr 26;65(4):383-393. doi: 10.1507/endocrj.EJ17-0456. Epub 2018 Mar 23.

9.

Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism.

Umakoshi H, Ogasawara T, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Suzuki T, Tsuiki M, Naruse M.

Clin Endocrinol (Oxf). 2018 May;88(5):645-651. doi: 10.1111/cen.13582. Epub 2018 Mar 13.

PMID:
29464741
10.

Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation.

Kawanami T, Tanaka T, Hamaguchi Y, Nomiyama T, Nawata H, Yanase T.

Endocrinology. 2018 Apr 1;159(4):1774-1792. doi: 10.1210/en.2018-00099.

PMID:
29444261
11.

The first report of human meningitis and pyogenic ventriculitis caused by Streptococcus suis: A case report.

Yanase T, Morii D, Kamio S, Nishimura A, Fukao E, Inose Y, Honma Y, Kitahara N, Yokozawa T, Chang B, Oda T.

J Infect Chemother. 2018 Aug;24(8):669-673. doi: 10.1016/j.jiac.2018.01.009. Epub 2018 Feb 9.

PMID:
29429850
12.

Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group.

Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22.

PMID:
29358460
13.

Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives.

Yanase T, Kawanami T, Tanaka T, Tanabe M, Nomiyama T.

Reprod Med Biol. 2017 Jun 12;16(3):252-257. doi: 10.1002/rmb2.12039. eCollection 2017 Jul. Review.

14.

Frailty in elderly diabetes patients.

Yanase T, Yanagita I, Muta K, Nawata H.

Endocr J. 2018 Jan 30;65(1):1-11. doi: 10.1507/endocrj.EJ17-0390. Epub 2017 Dec 14.

15.

Transition of Akabane virus genogroups and its association with changes in the nature of disease in Japan.

Yanase T, Kato T, Hayama Y, Akiyama M, Itoh N, Horiuchi S, Hirashima Y, Shirafuji H, Yamakawa M, Tanaka S, Tsutsui T.

Transbound Emerg Dis. 2018 Apr;65(2):e434-e443. doi: 10.1111/tbed.12778. Epub 2017 Nov 29.

PMID:
29193771
16.

Plasminogen activator inhibitor-1 is an independent prognostic factor of ovarian cancer and IMD-4482, a novel plasminogen activator inhibitor-1 inhibitor, inhibits ovarian cancer peritoneal dissemination.

Nakatsuka E, Sawada K, Nakamura K, Yoshimura A, Kinose Y, Kodama M, Hashimoto K, Mabuchi S, Makino H, Morii E, Yamaguchi Y, Yanase T, Itai A, Morishige KI, Kimura T.

Oncotarget. 2017 Sep 12;8(52):89887-89902. doi: 10.18632/oncotarget.20834. eCollection 2017 Oct 27.

17.

Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism.

Umakoshi H, Tsuiki M, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Yanase T, Suzuki T, Naruse M; JPAS Study Group.

J Clin Endocrinol Metab. 2018 Mar 1;103(3):900-908. doi: 10.1210/jc.2017-01774.

PMID:
29092077
18.

Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation.

Iwaya C, Nomiyama T, Komatsu S, Kawanami T, Tsutsumi Y, Hamaguchi Y, Horikawa T, Yoshinaga Y, Yamashita S, Tanaka T, Terawaki Y, Tanabe M, Nabeshima K, Iwasaki A, Yanase T.

Endocrinology. 2017 Dec 1;158(12):4218-4232. doi: 10.1210/en.2017-00461.

PMID:
29045658
19.

Meteorological factors affecting seroconversion of Akabane disease in sentinel calves in the subtropical Okinawa Islands of Japan.

Hayama Y, Yanase T, Suzuki M, Unten K, Tomochi H, Kakehi M, Shono Y, Yamamoto T, Kobayashi S, Murai K, Tsutsui T.

Trop Anim Health Prod. 2018 Jan;50(1):209-215. doi: 10.1007/s11250-017-1404-7. Epub 2017 Sep 20.

PMID:
28932950
20.

Fabrication of Epitaxial Fe3O4 Film on a Si(111) Substrate.

Takahashi N, Huminiuc T, Yamamoto Y, Yanase T, Shimada T, Hirohata A, Nagahama T.

Sci Rep. 2017 Aug 1;7(1):7009. doi: 10.1038/s41598-017-07104-z.

Supplemental Content

Loading ...
Support Center